|
Since the device has not been returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors can be made.As such, the investigation will be closed.If the complaint device is received in the future, the investigation will be reopened and conducted as appropriate.A manufacturing record evaluation (mre) was performed, and no anomalies were found related to this complaint.In addition, the mre verifies that the device was manufactured in accordance with documented specification and procedures.Reason for device explant and/or reoperation: breast cancer.Section d6b, date of explant: (b)(6) 2023.Mentor is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which mentor has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, mentor, or its employees that the report constitutes an admission that the device, mentor, or its employees caused or contributed to the potential event described in this report.If certain information is unknown, not available or does not apply, the section/field of the form is left blank.Manufacturer¿s reference number: (b)(4).
|
|
It was reported that a 67-year-old caucasian female patient underwent a primary breast augmentation with two 225cc mentor smooth round spectrum saline breast prostheses and was diagnosed with breast cancer post-operatively.At this time, the results of pathology report have not been provided.As a result, the patient underwent bilateral explantation and bilateral mastectomy on (b)(6) 2023.This report is for the left side device.
|